CSCs from both cell lines showed higher expression of ASCT2 in comparison with mature cancer cells, and knockdown of ASCT2 significantly decreased the proportion of CSCs (CD133+ CD44+) in comparison with control small interfering RNA (Fig. 1A). This evidence concerns the gene SLC1A5 and cancer.